DrugPatentWatch Database Preview

Akorn Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AKORN, and what generic alternatives to AKORN drugs are available?

AKORN has two hundred and sixty-three approved drugs.

There are five US patents protecting AKORN drugs. There are two tentative approvals on AKORN drugs.

There are seventy-four patent family members on AKORN drugs in thirty-one countries and two hundred and seventy-one supplementary protection certificates in fifteen countries.

Summary for Akorn

International Patents:	74
US Patents:	5
Tradenames:	192
Ingredients:	172
NDAs:	263
PTAB Cases with Akorn as petitioner:	See PTAB cases with Akorn as petitioner

Drugs and US Patents for Akorn

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Akorn	GABAPENTIN	gabapentin	SOLUTION;ORAL	078974-001	Feb 18, 2011	AA	RX	No	No
Akorn	EPINASTINE HYDROCHLORIDE	epinastine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	204055-001	May 5, 2017	AT	RX	No	No
Akorn	TIMOLOL	timolol	SOLUTION/DROPS;OPHTHALMIC	205309-001	Sep 30, 2016	AT	RX	No	No
Akorn	TROPICACYL	tropicamide	SOLUTION/DROPS;OPHTHALMIC	040314-001	Sep 29, 2000	AT	RX	No	No
Akorn	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	OIL;TOPICAL	091514-001	Jun 25, 2015		DISCN	No	No

Expired US Patents for Akorn

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Akorn	XOPENEX	levalbuterol hydrochloride	SOLUTION;INHALATION	020837-004	Jul 18, 2003	5,547,994
Akorn	XOPENEX	levalbuterol hydrochloride	SOLUTION;INHALATION	020837-001	Mar 25, 1999	5,362,755
Akorn	COSOPT	dorzolamide hydrochloride; timolol maleate	SOLUTION/DROPS;OPHTHALMIC	020869-001	Apr 7, 1998	4,797,413*PED
Akorn	XOPENEX	levalbuterol hydrochloride	SOLUTION;INHALATION	020837-003	Jan 30, 2002	5,547,994
Akorn	BETIMOL	timolol	SOLUTION/DROPS;OPHTHALMIC	020439-002	Mar 31, 1995	5,231,095

Paragraph IV (Patent) Challenges for AKORN drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Ophthalmic Solution	2%/0.5%		2005-10-11
	Inhalation Solution	0.0103%, 0.021% and 0.042%		2005-06-20
	Inhalation Aerosol	0.045 mg/actuation		2012-02-27
	Ophthalmic Solution	1%		2011-03-03
	Ophthalmic Solution	0.0015%		2016-02-10
	Inhalation Solution	0.0025		2006-05-23

International Patents for Akorn Drugs

Country	Patent Number	Estimated Expiration
Portugal	3205334
Taiwan	201000104
Croatia	P20200998
Slovenia	2772249
Brazil	PI0913109

Supplementary Protection Certificates for Akorn Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1856135	2090014-8	Sweden		PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE OR SOLVATE OF FOSTAMATINIB OR THE PH ARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113
2365988	CA 2018 00006	Denmark		PRODUCT NAME: PATIROMER SORBITEX CALCIUM AND ANY SALTS AND DERIVATIVES THEREOF; REG. NO/DATE: EU/1/17/1179/001-009 20170721
2365988	122018000012	Germany		PRODUCT NAME: PATIROMER SORBITEX CALCIUM UND SALZE DAVON IN ALLEN VOM GRUNDPATENT GESCHUETZTEN FORMEN; REGISTRATION NO/DATE: EU/1/17/1179 20170719
1429780	122012000070	Germany		PRODUCT NAME: KOMBINATION AUS CIPROFLOXACIN UND DEXAMETHASON, INSBESONDERE CIPROFLOXACINHYDROCHLORID UND DEXAMETHASON; NAT. REGISTRATION NO/DATE: 85150.00. 00 20120830; FIRST REGISTRATION: DAENEMARK 48976 20120808
2203431	92666	Luxembourg		PRODUCT NAME: DASABUVIR OU UN SEL QUI EN DERIVE, Y COMPRIS DASABUVIR SODIUMMONOHYDRATE. FIRST REGISTRATION: 20150119

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Akorn